Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers

计划入组 209 人 · 首次发布于 2021 年 6 月 23 日

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam

计划入组 447 人 · 首次发布于 2024 年 1 月 29 日

Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China

计划入组 4,568 人 · 首次发布于 2026 年 7 月 17 日

Mencevax

Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine(Menveo)

Meningococcal Groups A, B, C, W, and Y Vaccine (Pfizer)

CATALENT ARGENTINA S.A.I. y C.

Argentina

Shanxi C&y Pharmaceutical Group Co.,Ltd

YMCA

United States

GSK's Single-Vial, Fully Liquid Menveo Receives Positive CHMP Opinion for Meningococcal Disease Prevention

FDA Expands MenQuadfi Meningococcal Vaccine Approval to Include Infants as Young as 6 Weeks

Sanofi's MenQuadfi Wins EU Approval for Infants from Six Weeks of Age Against Invasive Meningococcal Disease